We are the world leading CDMO
for microbiome therapeutics
and Next Generation Probiotics

We truly believe that health is managed by the beneficial collaboration between human cells and microbes

Figures

Key Figures

A brief insight into our industrial activity last year

75

tonnes of drug substance

120

Million capsules

+30

DIFFERENT CLINICAL LINES

+300

different strains in development

values

Core values

Commitment

Agility

Responsibility

Expertise

dna

Our DNA

Vision

The use of microorganisms creates a new category of innovative drugs. Biose Industrie is the world leader in the bioproduction of microbiome therapeutics.

Identity

Global CDMO and pioneer of pharmaceutical microbiome therapeutics, integrating our analytical and industrial know-how to support our customers from project development to the commercial launch of their products.

Mission

Accelerate project success and client satisfaction.
Drive and develop our expertise and our bioproduction capacity.
Anticipate regulatory requirements and changing market needs.

One-stop CDMO

Welcome to our one-stop CDMO

Scaling Multi-Strain LBPs: A Journey Between Microbiotica and Biose Industrie
October 10, 2024

Scaling Multi-Strain LBPs: A Journey Between Microbiotica and Biose Industrie

...
Read More
A Powerful Partnership: Biose and Biomica took to the stage at the 2024 Pharmabiotics Event in Lille
April 18, 2024

A Powerful Partnership: Biose and Biomica took to the stage at the 2024 Pharmabiotics Event in Lille

One in two people will develop cancer in their lifetime. Given this startling fact, developing novel treatments to improve cancer survivability is vital. ...
Read More
11 February: International Day of Women and Girls in Science
February 11, 2024

11 February: International Day of Women and Girls in Science

Today, on the International Day of Women and Girls in Science 2024, we celebrate the importance of achieving gender equality at work and we recognize the role that women and girls play in science and technology. ...
Read More